Eric Levin is the CEO and cofounder of Scripta.
Oral vs Injectable GLP-1 Cost-Saving Strategies: Eric Levin
Oral Wegovy shifts GLP-1 obesity costs: insurance may match injectables, while cash-pay and pharmacy platforms unlock lower prices and aid programs.